On October 31, during the 19th Laboratory Medicine Academic Conference of the Chinese Medical Association, the signing ceremony of strategic cooperation between Ningbo Haiershi Gene Technology Co., Ltd. and Rocgene (Beijing) Scientific Instrument Co., Ltd. was held at the Shandong International Convention and Exhibition Center. This cooperation mainly focuses on the implementation and deployment of molecular POCT respiratory products.

> remainder

Chairman and CEO of Heirsch

Gene< img src="https://s-files.bcdn8.com/kunpeng0320/uploads/20260210/efc371d927593062b6b31fb517afcfc0.webp" alt="" />

At the ceremony, Mr. Yu Ding, chairman and CEO of Haiersch Gene, said that the concepts of Haiersch Gene and Rocgene in technological innovation and customer service are highly consistent. Haiersch Gene is deeply involved in capillary electrophoresis technology in the field of respiratory molecular testing, and is committed to popularizing multiplex nucleic acid testing to hospitals and patients. Rocgene's POCT platform is fast, flexible, and easy to meet the needs of specialized medical rapid testing.

have reached a strategic cooperation and will leverage their respective advantages to give full play to synergies to further provide full-chain solutions covering the needs of outpatient and emergency rapid nucleic acid testing and laboratory diagnosis in the field of respiratory infections.

Guo Qiuzhen

the chairman and CEO of Rocgene

Mr. Guo Qiuzhen, Director and General Manager of Rocgene, spoke highly of Haiersch Gene's efforts in the field of respiratory infections over the years. Rocgene has been deeply involved in molecular POCT for many years, and has the same concept as Haiersch genes, and has launched the iFIND molecular POCT platform that is fully independently developed and produced after years of polishing. Choosing Haiersch Gene as the exclusive partner in the respiratory field will surely be a strong joint effort that will definitely bring more and better products to the market.

about the Heelsch gene

Ningbo Haiershi Gene Technology Co., Ltd. (HGT) is a high-tech enterprise focusing on the research and development, production, sales and service of medical laboratory technology and related products, is a national-level specialized and new "little giant" enterprise, a national postdoctoral workstation, with 86 Chinese invention patents and 3 international invention patents, and has won the first prize of Zhejiang Science and Technology Progress Award, the first prize of Ningbo Science and Technology Progress Award, and the bronze medal of the "Double Ten Plan" Innovation Competition of the Ministry of Public Security.

The business covers two major fields: clinical testing and forensic science, with the corporate mission of "making society safer and healthier life", and is committed to providing comprehensive medical testing application solutions such as molecular diagnosis, immunodiagnosis, and biochemical diagnosis for medical institutions at all levels, third-party testing, and the Center for Disease Control and Prevention, as well as providing complete technical solutions such as DNA testing products and mass spectrometry analysis products for public security systems and appraisal institutions.

About Rocgene Rocgene

(Beijing) Scientific Instruments Co., Ltd. was founded in 2016 and is a bio-high-tech company founded by scientists and business people and driven by core technologies. Rocgene is committed to transforming new technologies in the field of life science research into clinically relevant medical research products, and developing scientific research and molecular diagnostic products with independent intellectual property rights.

Rocgene has won many honorary titles such as "National High-tech Enterprise", "Specialized, Special and New" Small and Medium-sized Enterprises in Beijing, and "Zhongguancun High-tech Enterprise". At present, it has obtained 5 registration certificates for Class III medical devices in China, 20 registration certificates for Class I medical devices, and 34 CE certifications, 4 US FDA certifications, 4 UK MHRA certifications, and 3 Indonesian NADFC certifications. 69 patents have been obtained: including 42 invention patents, 13 utility model patents, and 14 appearance patents; Obtained 47 software copyright certificates. Up to now, Rocgene's products have been exported to nearly 20 countries around the world.